JP Morgan Chase’s AbCellera Biologics ABCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$255K Buy
77,618
+4
+0% +$14 ﹤0.01% 5356
2025
Q4
$265K Sell
77,614
-53,050
-41% -$237K ﹤0.01% 5381
2025
Q3
$657K Sell
130,664
-4,777
-4% -$21.1K ﹤0.01% 4866
2025
Q2
$465K Sell
135,441
-68,812
-34% -$171K ﹤0.01% 4822
2025
Q1
$455K Sell
204,253
-76,780
-27% -$220K ﹤0.01% 4842
2024
Q4
$823K Sell
281,033
-74,714
-21% -$208K ﹤0.01% 4760
2024
Q3
$925K Buy
355,747
+21,483
+6% +$59.5K ﹤0.01% 4514
2024
Q2
$989K Sell
334,264
-36,501
-10% -$138K ﹤0.01% 4288
2024
Q1
$1.68M Sell
370,765
-38,494
-9% -$196K ﹤0.01% 3982
2023
Q4
$2.34M Sell
409,259
-127,035
-24% -$589K ﹤0.01% 3715
2023
Q3
$2.47M Buy
536,294
+61,563
+13% +$375K ﹤0.01% 3405
2023
Q2
$3.07M Sell
474,731
-236,555
-33% -$1.61M ﹤0.01% 3234
2023
Q1
$5.36M Buy
711,286
+118,102
+20% +$1.07M ﹤0.01% 2761
2022
Q4
$6.01M Buy
593,184
+93,054
+19% +$1.07M ﹤0.01% 2675
2022
Q3
$4.95M Buy
500,130
+90,026
+22% +$988K ﹤0.01% 2748
2022
Q2
$4.37M Buy
410,104
+259,222
+172% +$2.19M ﹤0.01% 2895
2022
Q1
$1.47M Buy
150,882
+68,844
+84% +$652K ﹤0.01% 3994
2021
Q4
$1.17M Buy
+82,038
New +$1.24M ﹤0.01% 4265

Other funds holding ABCL